Andrew Zambanini

Effects of the Direct Lipoprotein-Associated Phospholipase A ₂ Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque

Patrick W. Serruys, Héctor M. García‐García, Paweł Buszman et al. · Circulation · 2008 · 505 citations · Full text

Medicine, Cardiology, Pharmacology +17

Injection related anxiety in insulin-treated diabetes

Andrew Zambanini, Roger Newson, M.N. Maisey et al. · Diabetes Research and Clinical Practice · 1999 · 286 citations

Medicine, Endocrinology, Internal Medicine +10

Tissue Doppler E/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy

Andrew S.P. Sharp, Robyn J. Tapp, Simon Thom et al. · European Heart Journal · 2009 · 208 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

A Randomized, Placebo-Controlled Trial Assessing the Effects of Rosiglitazone on Echocardiographic Function and Cardiac Status in Type 2 Diabetic Patients With New York Heart Association Functional Class I or II Heart Failure

Henry J. Dargie, Per Hildebrandt, Günter A.J. Riegger et al. · Journal of the American College of Cardiology · 2007 · 206 citations

Medicine, Cardiology, Pharmacology +13

Curvature and tortuosity of the superficial femoral artery: a possible risk factor for peripheral arterial disease

Nigel B. Wood, Sarah Zhao, Andrew Zambanini et al. · Journal of Applied Physiology · 2006 · 146 citations

Medicine, Anatomy, Biomedical Imaging +11